Printer Friendly
The Free Library
19,585,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Advanced Optics Electronics Inc. Announces 13D Filed.


ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Jan. 4, 1999--Advanced Optics Electronics Inc. (OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
 BB:ADOT ADOT Arizona Department Of Transportation
ADOT Alaska Department of Transportation
ADOT Fédération des Associations pour le Don d'Organes et de Tissus Humains
ADOT Active Duty Other Than Training
ADOT Automatic Digital Optical Tracker
ADOT Advanced Display Optimization Tools
) Monday announced that a regulation 13D (a disclosure form showing beneficial ownership) was filed by D TECH for the law firm of Lynch, Rowin, Novack, Burnbaum and Crystal's reporting person, Y.L. Hirsch of Israel.

The 13D disclosed that the purpose of the transaction was for "investment purposes only and not with a view to resale or distribution." Management will be working with Hirsch discussing future direction of the company.

Advanced Optics Electronics Inc. is a developer of patented electronic display technology, utilizing ADOT's proprietary SLM See service level management system and spatial light modulator.  (Spatial Light Modulator (1) A matrix of movable mirrors used to reflect a digital image to the viewer. See DLP.

(2) A matrix of shutters that represents a page of binary data. It is used to modulate a laser beam for holographic storage. See holographic storage.
) light valve.

This industry-leading technology can be utilized in many diverse fields including the production of "television quality" advertising billboards, medical testing equipment, military displays, computer monitors and high definition video transmission.

In addition to the core business of ADOT, the company has identified and placed a strategic and high potential return investment in BioModa Inc. BioModa Inc. is a company that holds patents and patents pending domestically and internationally in the technology for early detection of lung cancer lung cancer, cancer that originates in the tissues of the lungs. Lung cancer is the leading cause of cancer death in the United States in both men and women. Like other cancers, lung cancer occurs after repeated insults to the genetic material of the cell. .

ADOT currently holds approximately 23 percent of BioModa Inc. with an option to increase that position to 26.4 percent. BioModa Inc. intends to do an IPO (Initial Public Offering) The first time a company offers shares of stock to the public. While not a computer term per se, many founders, employees and insiders of computer companies have found this acronym more exciting than any tech term they ever heard.  within the next two years.

Note to Editors: This News Release contains forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 with respect to the results of operations and business of the company that involves risk and uncertainties. The company's actual future results could materially differ from those discussed. Risks and uncertainties of the company will be detailed from time to time in the company's periodic reports to be filed with the Securities and Exchange Commission.

Contact Advanced Optics Electronics Inc. at 505/797-7878 or visit their Web site at www.adot.org.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jan 4, 1999
Words:295
Previous Article:DataLink Changes Stock Symbol to NETD.
Next Article:Phase Forward Partners With InfoMedics; Phone and Web Technologies Enable Complete Management of Patient Data During Clinical Trials.
Topics:



Related Articles
Fidelity Medical announcement of schedule 13D filing with Securities and Exchange Commission.
SEC schedules 13D and 13G can help determine sec. 382 ownership changes.
Advanced Optics Electronics Inc. Announces They Have Become Fully Reporting.
Advanced Optics Electronics Inc. announces the filing of new patent.
Advanced Optics Electronics Inc. Announces Fiber Optics Acquisition.
Advanced Optics Electronics Inc. Announces Additional Information.
Advanced Optics Electronics Inc. Announces Updated Coverage and Beta Testing Schedule.
Advanced Optics Electronics Inc. Announces Positive Outlook for 2001.
Advanced Optics Electronics Inc. Announces Recent Developments.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles